Results 161 to 170 of about 438,048 (258)
Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study. [PDF]
Wei C +7 more
europepmc +1 more source
Comparative Study of Free and Total Fatty Acids of Spreadable Cheeses by Mass Spectrometry Methods
This study focuses on the determination of FFAs in spreadable cheeses and alternatives using a fast Liquid Chromatography‐High Resolution Mass Spectrometry method. A Gas Chromatography‐Mass Spectrometry method was used to determine the composition (%) of total FAs in the same samples.
Christiana Mantzourani +6 more
wiley +1 more source
Hepatoprotective effects of cinnamaldehyde against high-fat diet-induced liver damage. [PDF]
Farmani R +4 more
europepmc +1 more source
Surface‐bound ferulate phenolate complexes undergo styrene‐like polymerization on alumina, yielding a polymeric carbonaceous layer that progressively transforms into polyaromatic carbon domains with concomitant release of aromatic products, while parallel surface‐assisted decarboxylation produces 4‐vinylguaiacol. ABSTRACT A fundamental understanding of
Tetiana V. Kulik +11 more
wiley +1 more source
Reduced Cardiovascular Risk Indicated by Changes in Triglyceride-Glucose Index After Pancreas Transplantation. [PDF]
Skrzypek P +8 more
europepmc +1 more source
Abstract Global energy demand and environmental concerns have intensified the search for renewable and sustainable energy sources. This study thus, focuses on optimizing the transesterification process of waste cooking oil (WCO) using thermally activated basic oxygen furnace slag catalyst calcined at 850°C (BOF 850). The optimization and modelling were
Johra S. Ali, Hillary L. Rutto
wiley +1 more source
Association of triglyceride-glucose index and triglyceride-glucose body mass index with risk and prognosis of chronic obstructive pulmonary disease: a systematic review and meta-analysis. [PDF]
Wu Y, Wu N, Gao L.
europepmc +1 more source
Obeticholic acid (OCA), a synthetic analog of chenodeoxycholic acid, was approved in 2016 for the treatment of primary biliary cholangitis. Early clinical trials revealed elevated liver biomarkers in healthy subjects receiving supratherapeutic OCA doses (100–250 mg).
Abigail K. Mayo +4 more
wiley +1 more source

